转移性三阴性乳腺癌的免疫检查点抑制剂的未来是什么 ?
求助全文
关键词: KEYNOTE-355 PARP inhibitors atezolizumab breast cancer immune checkpoint niraparib pembrolizumab talazoparib triple negative tumor-infiltrating lymphocytes
来 源: DOI:10.2217/imt-2024-0030